Form 4 for RGEN REPLIGEN CORP
Accepted 2026-03-03 00:00:00 ET · period of report 2026-03-02 · accession 0001193125-26-087447 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-03 | 2026-03-02 | RGEN | Douglass Brian Robb | Chief PRODUCT Off | F - Tax | $124.97 | -221 | 8,319 | -3% | -$27.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-02 | F | D | 221 | $124.97 | 8,319 | D | — | — | (F1) Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units. |